drugset / Trial / NCT03300765
Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
NaSingle-groupOpen-labelTreatment
Summary
To determine the efficacy and safety of intensity modulated radiation therapy combined with apatinib for inoperable or iodine refractory thyroid cancer.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2019-07-01
- Completion
- 2020-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 0.5 g | — |